What was reported
Cambrian Bio filed a Form D with the SEC on Jul 15, 2026 and reported $123,751,064 sold of a $129,751,064 offering, with the first sale on Jun 30, 2026. 80 investors had invested.
What the evidence supports
Cambrian Bio told the SEC, in a notice filed Jul 15, 2026, that it had $123,751,064 of equity sold in an offering exempt from registration under Rule 506(c).
What remains unknown
A Form D is a notice: the SEC does not review or approve it. It does not state the company's valuation, the price paid, who invested, or how the money will be used, and the amount can span several closings. Rule 506(c) lets the company advertise the offering but sell only to investors it has verified as accredited. This record describes a past sale; it is not an offer, and it does not mean shares are available to buy.
Figures as stated
Numbers exactly as written in the source. We don’t annualise, convert or add them up.
| Figure | In context |
|---|---|
| $123,751,064 | “Total amount sold: $123,751,064” Mentions: offering |
| $129,751,064 | “Total offering amount: $129,751,064” Mentions: offering |
Source passages
Exact excerpts from the source, with links. Quotes are checked character for character against our stored copy.
Amount sold to date (Form D; cumulative, not a valuation)Total amount sold: $123,751,064U.S. Securities and Exchange Commission (EDGAR) · Form D: notice of exempt offering of securities · Jul 15, 2026 · Open the source ↗
Total offering amount (Form D; the most the company said it would sell)Total offering amount: $129,751,064U.S. Securities and Exchange Commission (EDGAR) · Form D: notice of exempt offering of securities · Jul 15, 2026 · Open the source ↗
Form D noticeForm D: notice of exempt offering of securities, filed with the SEC on 2026-07-15 (accession 0000950172-26-000183)U.S. Securities and Exchange Commission (EDGAR) · Form D: notice of exempt offering of securities · Jul 15, 2026 · Open the source ↗
Industry group as stated by the companyIndustry group (as stated by the issuer): BiotechnologyU.S. Securities and Exchange Commission (EDGAR) · Form D: notice of exempt offering of securities · Jul 15, 2026 · Open the source ↗
Date of first sale (Form D)Date of first sale: 2026-06-30U.S. Securities and Exchange Commission (EDGAR) · Form D: notice of exempt offering of securities · Jul 15, 2026 · Open the source ↗
Investor count (Form D)Investors who have already invested: 80U.S. Securities and Exchange Commission (EDGAR) · Form D: notice of exempt offering of securities · Jul 15, 2026 · Open the source ↗
Exemption claimed (Form D)Exemption claimed: Rule 506(c)U.S. Securities and Exchange Commission (EDGAR) · Form D: notice of exempt offering of securities · Jul 15, 2026 · Open the source ↗
Revision history
- Revision 1 · Oct 28, 2026, 20:53 UTC
Cambrian Bio reports $123.8 million of equity sold in a private offering
Spotted an error? Tell us. Corrections are published, never silent: see all corrections.